Sylvia L. Asa, MD, PhD, Endocrine Pathologist, University Hospitals Cleveland and Professor of Pathology, Case Western Reserve University, is a Clinician-Scientist with a focus on Endocrine Pathology; her research aims to identify the basis for development of endocrine tumors, to improve diagnostic tests and to identify targets for therapy of those diseases. She has published over 600 scientific articles and 150 book chapters, written eight books, co-edited nine books including the 5th Edition WHO Classification of Endocrine and Neuroendocrine Tumours, and given over 300 invited lectures. She serves on numerous journal editorial boards. Dr. Asa was President of the Endocrine Pathology Society (1997–1998) and the US-Canadian Academy of Pathology (2005-6) and has received numerous awards from national and international scientific organizations.

As head of Canada’s largest pathology department for 15 years, Dr. Asa made innovative changes to the practice of the discipline, implementing subspecialization, molecular diagnostics, biobanking, automation, pathology informatics and digital pathology. She emphasizes the importance of education and research. To ensure public knowledge of the role of Pathology and maintain a direct connection with patients, Dr. Asa is a consultant to several patient groups.

Dr. Emina Emilia Torlakovic obtained her M.D. at the University of Zagreb Medical School and her Ph.D. at the University of Oslo Medical School. She is board certified by The American Board of Pathology in Anatomic and Clinical Pathology with subspecialty boards in Hematopathology. She is a professor at the Department of Pathology and Laboratory Medicine, College of Medicine, University of Saskatchewan. She is a Division Head of Hematopathology, Saskatchewan Health Authority. She was a founding member of the NordiQC, has co-founded CIQC, and most recently founded Canadian Biomarker Quality Assurance (CBQA) as well as CBQAReadout.ca (inter)national academic quality assurance programs, which she is currently directing. Dr. Torlakovic is the Chair of the National Standards Committee for High Complexity Testing of the Canadian Association of Pathologists. She is the President of the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) and a Board Member of the International Quality Network for Pathology (IQN Path). She is also currently leading several projects related to national and global standardization of clinical IHC applications.